Pay in 4 interest-free payments of $59.38 Learn more
Ships within 48 hours · Estimated delivery Aug 5 - Aug 10
TSA 840-d6
Arg8 is separated from the MUC1 sequence by Cys-Gly-Ser-Gly
the innermost N-glycan residue with the α1-6 core fucose that modulates antibody effector function and is a focus of biopharmaceutical glycoengineering
/ Fmoc-Ser(Man(Ac)4-α-D)-OH / Fmoc-L-Ser(Man(Ac)4-α-D)-OH
2-[3-Cyano-4-(2-methylpropoxy)phenyl]-4-methyl-5-thiazolecarboxylate ß-D-Glucopyranuronic Acid
GP900115: MUC4(1179-1194)-TF(1183) Pack Size:1 mg TSA 840-d6C78H128N20O35 1905. 96 Synthetic glycopeptide fragment (Thr1179 Asp1194; UniProt position 1179 1194, aa length 16) from the variable number tandem repeat (TR) domain. The fragment contains tumour associated carbohydrate antigen (TACA), TF antigen, O glycosylation (Gal1 3GalNAc) at Ser1183. The C terminus is an amide. MUC4(1179 1194) TF(1183) Mucin4; Synthetic MUC 4 (TF) glycopeptide; TRMUC4 Ser5 Tn
